Psychopharmacology of Depression as a Systemic Illness for Primary and Specialty Care Clinicians Focus on Adverse Drug Reactions and Drug–Drug Interactions

KL Cozza, R Rein, GH Wynn… - Depression as a Systemic …, 2018 - books.google.com
Drug–drug interactions (DDIs) are an important, but often overlooked and underrecognized
clinical issue in psychosomatic medicine. The frequency of DDIs, especially with …

Antidepressant drug-drug interactions: clinical relevance and risk management

CB Nemeroff, SH Preskorn, CL DeVane - CNS Spectrums, 2007 - cambridge.org
Multiple medication use is a common phenomenon, especially in patients with comorbid
conditions and those treated with psychiatric drugs such as antidepressants. Combination …

Treating depression: potential drug-drug interactions: commentary

L Ereshefsky - Journal of clinical psychopharmacology, 1996 - journals.lww.com
WIDE VARIETY OF adverse drug reactions (ADRs), which include drug-drug interactions,
are responsible for a significant number–3% to 7%–of hos-pital admissions. From these …

Antidepressant drug-drug interaction profile update

L Ereshefsky, S Jhee, D Grothe - Drugs in R & D, 2005 - Springer
Drug-drug interactions continue to be underappreciated and misunderstood by most
clinicians. Although life-threatening drug interactions are rare, serious clinical …

Drug-drug interactions (DDIs) in psychiatric practice, part 9: interactions mediated by drug-metabolizing cytochrome P450 enzymes

SH Preskorn - Journal of Psychiatric Practice®, 2020 - journals.lww.com
This column is the ninth in a series exploring drug-drug interactions (DDIs) with a special
emphasis on psychiatric medications. The first 3 columns in this DDI series discussed why …

Drug-drug interactions (DDIs) in psychiatric practice, part 8: relative receptor binding affinity as a way of understanding the differential pharmacology of currently …

SH Preskorn - Journal of Psychiatric Practice®, 2020 - journals.lww.com
This column is the eighth in a series exploring drug-drug interactions (DDIs) with a special
emphasis on psychiatric medications. The first 3 columns in this DDI series discussed why …

Drug-drug interactions (DDIs) in psychiatric practice, part 2: strategies to minimize adverse outcomes from unintended DDIs

SH Preskorn - Journal of Psychiatric Practice®, 2018 - journals.lww.com
This column is the second in a series exploring drug-drug interactions (DDIs) with a special
emphasis on psychiatric medications. The first column in this series discussed why patients …

[HTML][HTML] Assessment of drug-related problems in depressive patients

UV Mateti, T Lalwani, AN Nagappa… - … in Clinical Research, 2015 - journals.lww.com
Background: Drug-related problems (DRPs) frequently occur in modern medical practice,
increasing the morbidity and mortality as well as increasing cost of care. Objective: The …

Drug interactions of antidepressants

L Ereshefsky - Psychiatric Annals, 1996 - journals.healio.com
The drug interaction potential of antidepressants is an important consideration in selecting
an appropriate pharmacotherapcutic intervention. The total cost of health care for a …

Drug-drug interactions (DDIs) in psychiatric practice, part 3: pharmacokinetic considerations

SH Preskorn - Journal of Psychiatric Practice®, 2019 - journals.lww.com
This column is the third in a series exploring drug-drug interactions (DDIs) with a special
emphasis on psychiatric medications. The first column in this series discussed why patients …